MERLINI, Luciano
 Distribuzione geografica
Continente #
NA - Nord America 2.102
EU - Europa 712
AS - Asia 308
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.124
Nazione #
US - Stati Uniti d'America 2.098
PL - Polonia 250
CN - Cina 177
DE - Germania 107
UA - Ucraina 107
TR - Turchia 73
IT - Italia 71
GB - Regno Unito 69
SG - Singapore 39
SE - Svezia 34
FI - Finlandia 31
BE - Belgio 16
RU - Federazione Russa 12
ID - Indonesia 8
CZ - Repubblica Ceca 7
VN - Vietnam 4
CA - Canada 3
ES - Italia 3
IN - India 3
IR - Iran 3
NL - Olanda 3
FR - Francia 2
BR - Brasile 1
EU - Europa 1
JO - Giordania 1
PA - Panama 1
Totale 3.124
Città #
Fairfield 310
Woodbridge 281
Warsaw 250
Ann Arbor 185
Chandler 175
Ashburn 153
Houston 134
Seattle 124
Jacksonville 123
Cambridge 98
Wilmington 89
Beijing 51
Izmir 48
Nanjing 28
Princeton 28
Milan 26
Boardman 24
San Diego 24
New York 23
Singapore 23
Bremen 22
Shanghai 22
Ferrara 18
Brussels 14
Shenyang 13
Dearborn 11
Los Angeles 10
Nanchang 10
Falls Church 9
Helsinki 8
Tianjin 8
Washington 8
Brno 7
Jakarta 7
Hebei 6
Munich 6
San Mateo 6
Changsha 5
Kunming 5
London 5
Norwalk 5
Auburn Hills 4
Bologna 4
Des Moines 4
Jiaxing 4
Jinan 4
Addison 3
Dong Ket 3
Hangzhou 3
Lanzhou 3
Leawood 3
Mountain View 3
Ningbo 3
Redwood City 3
Zhengzhou 3
Ardabil 2
Augusta 2
Borgo Val di Taro 2
Brescia 2
Chicago 2
Hasselt 2
Hefei 2
Hounslow 2
Monmouth Junction 2
Palm Bay 2
Philadelphia 2
Phoenix 2
Prescot 2
Taizhou 2
Toronto 2
Varazze 2
Alpedrete 1
Amman 1
Antalya 1
Ceregnano 1
Changchun 1
Ferrara di Monte Baldo 1
Fuzhou 1
Groningen 1
Guarda Veneta 1
Hanoi 1
Irkutsk 1
Kilburn 1
Madrid 1
Montreal 1
New Bedfont 1
Orange 1
Panama City 1
Rueil-Malmaison 1
Saint Petersburg 1
Southwark 1
São Paulo 1
Trebaseleghe 1
Wandsworth 1
Totale 2.504
Nome #
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 324
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 192
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 148
Macrophages: a minimally invasive tool for monitoring collagen VI myopathies 141
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 140
Exon skipping-mediated dystrophin reading frame restoration for small mutations 138
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 137
Paternal germline mosaicism in collagen VI related myopathies 134
Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins 124
Autosomal recessive myosclerosis myopathy is a collagen VI disorder 122
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies 122
Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies 115
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 115
Androgen receptor gene (CAG)n repeat analysis in the differential diagnosis between Kennedy disease and other motoneuron disorders. 115
Melanocytes--a novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy 112
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 112
Early corticosteroid treatment in 4 duchenne muscular dystrophy patients: 14-year follow-up 109
Autosomal recessive Bethlem myopathy 108
Defective collagen VI α6 chain expression in the skeletal muscle of patients with collagen VI-related myopathies. 108
Transcriptional behavior of DMD gene duplications in DMD/BMD males 108
Identification and characterization of novel collagen VI non-canonical splicing mutations causing ullrich congenital muscular dystrophy 106
null 99
Correlazione morfo-funzionale del coinvolgimento muscolare in pazienti con Malattia di Pompe late-onset 85
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 85
Genomic and transcription studies as diagnostic tools for a prenatal detection of X-linked dilated cardiomyopathy due to a dystrophin gene mutation. 25
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 20
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 15
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 13
Totale 3.172
Categoria #
all - tutte 12.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.399


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020650 0 0 36 111 60 87 69 82 66 74 44 21
2020/2021431 41 40 18 56 37 38 17 48 11 48 56 21
2021/2022362 10 35 31 5 10 15 43 16 11 21 52 113
2022/2023408 29 51 2 60 95 39 28 29 38 4 20 13
2023/2024229 15 35 24 3 24 52 5 13 1 1 2 54
2024/202538 19 19 0 0 0 0 0 0 0 0 0 0
Totale 3.172